Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

导出 LinkOut

翻译打印收藏纠错

作者： Christos A,Papadimitriou ^[1] ; Haralambos,Kalofonos ; Flora,Zagouri ; Pavlos,Papakostas ; George,Bozas ; Thomas,Makatsoris ; Meletios-A,Dimopoulos ; George,Fountzilas

作者单位： Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece. ^[1]

主题词成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);脱氧胞苷(Deoxycytidine);女(雌)性(Female);人类(Humans);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);紫杉酚(Paclitaxel);紫杉烷类(Taxoids)

DOI 10.1159/000236021

PMID 19729979

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览11

Oncology

2009年77卷3-4期

212-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

Oncology

相似文献

Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

Oncology

相似文献

Oncology

相关期刊

检索历史清除